[Comorbidity in gout and hyperuricemia: prevalence, causes, prospects of urate lowering therapy]
1V.A. Nasonova Scientific and Research Institute of Reumatology.
Insights
Gout and asymptomatic hyperuricemia are linked to serious health issues like diabetes and heart disease. Lowering uric acid levels can improve joint health and slow the progression of these life-threatening conditions.
Area of Science:
- Nephrology
- Cardiology
- Rheumatology
Background:
- Gout and asymptomatic hyperuricemia are increasingly recognized for their association with comorbid conditions.
- These conditions include diabetes mellitus, cardiovascular diseases, hypertension, and chronic kidney disease.
Purpose of the Study:
- To explore the connection between gout, asymptomatic hyperuricemia, and comorbid conditions.
- To highlight the impact of urate crystal deposition on disease prognosis and progression.
Main Methods:
- Review of studies investigating the link between hyperuricemia and comorbidities.
- Analysis of the role of urate levels in cardiovascular and renal disease progression.
Main Results:
- Asymptomatic hyperuricemia, not just gout, can worsen cardiovascular disease prognosis.
- Urate crystal deposition is implicated in the cause and progression of renal failure.
Conclusions:
- Timely urate-lowering therapy is crucial.
- Achieving target serum uric acid levels can mitigate joint damage and slow the progression of life-threatening comorbidities.
Abstract:
Nowadays, there is increased interest in the connection of gout and asymptomatic hyperuricemia with comorbid conditions such as diabetes mellitus, cardiovascular diseases, hypertension, chronic kidney disease and other. Studies conducted over the past few decades suggest that not only gout, but also asymptomatic hyperuricemia can significantly worsen the prognosis in patients with cardiovascular diseases, as the deposition of urate crystals can be both an immediate cause and a factor in the progression of renal failure. In that way, the timely appointment of urate - lowering therapy and achieving the target serum uric acid level can not only affect joint damage, but also can significantly slow the progression of life - threatening comorbid conditions.
Related Concept Videos
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Urinary Tract Calculi V: Nursing Management
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
![Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F61682.jpg&w=3840&q=50)
